SHS Capital and its co-investors have sold Selfapy GmbH, a digital health firm focused on mental health, to MEDICE Health Family, marking MEDICE's expansion into integrated healthcare solutions.
Target Company Information
Selfapy GmbH, a pioneering company in the digital health sector, specializes in mental health solutions and has recently been acquired by MEDICE Health Family. With a focus on providing flexible, accessible online therapy programs, Selfapy offers CE-certified medical products designed to assist individuals facing various mental health challenges, including depression, generalized anxiety disorder, bulimia nervosa, binge-eating disorder, and chronic pain. These programs can be utilized on smartphones and tablets, and they may be prescribed by healthcare professionals, with their costs covered by Germany's statutory health insurance system. Developed by clinical psychologists, Selfapy's offerings emphasize a guideline-based therapeutic approach that is not reliant on medication, ensuring demonstrated effectiveness in addressing mental health issues.
Industry Overview in Germany
The digital health industry in Germany has been rapidly evolving, particularly in the realm of mental health solutions. With increasing recognition of mental health as a critical component of overall well-being, there is a growing emphasis on innovative therapeutic options. German healthcare providers are increasingly adopting digital interventions as part of broader treatment strategies, particularly in light of the growing demand for mental health services exacerbated by the COVID-19 pandemic.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
This market growth is supported by legislative efforts aimed at integrating digital health applications into the public health system, exemplified by the Digital Healthcare Act (DVG), which facilitates the prescription of
Similar Deals
MDG Molecular Diagnostics Group GmbH → oncgnostics GmbH
2025
SHS Capital → Ackermann Instrumente GmbH
2025
Serafin Unternehmensgruppe → Gross GmbH
2025
MEDICE – The Health Family
invested in
Selfapy GmbH
in 2025
in a Other Private Equity deal